Breaking News

You are here » Indian-Commodity  :  Commodities  :  Cardamom  :  Cardamom futures edge lower on MCX

31-Oct2017

Cardamom futures edge lower on MCX

Cardamom futures edged lower on MCX as speculators booked profits at prevailing levels amid easing demand in the spot market. Moreover, adequate stocks position following higher supply from the producing regions too fuelled the downtrend.

The contract for November delivery was trading at Rs 968.00, down by 0.64% or Rs 6.20 from its previous closing of Rs 974.20. The open interest of the contract stood at 183 lots.

The contract for December delivery was trading at Rs 969.00, down by 0.92% or Rs 9.00 from its previous closing of Rs 978.00. The open interest of the contract stood at 189 lots on MCX.


Related News

View all news

Cardamom futures decline on muted demand

Cardamom futures declined on MCX, as market participants trimmed their bets followed by muted demand from physical markets. Meanwhile, concerns about demand from UAE due to strict pesticide rule also weighed......

Cardamom futures tick higher on MCX

Cardamom futures declined on MCX, as speculators widened their positions counting heavy loses to crop amid recent floods. Besides, improved export and spot demand also fuelled the uptrend.The contract......

Cardamom futures trade higher on MCX

Cardamom futures traded higher on MCX, as speculators widened their holdings with the heavy rains in Kerala causing floods in several districts including largest cardamom growing-Idukki. Meanwhile, heavy......

Top News

View all news

Tijaria Polypipes bags order worth Rs 35.30 crore

Tijaria Polypipes has received a single order of Rs 35.30 crore for supply of HDPE & PLB Ducts from Tata Projects. The same has to be executed within a period of 3 months. The company takes great......

RIL's telecom arm enters into 5 year partnership with Star India

Reliance Industries' (RIL) telecom arm -- Reliance Jio Infocomm (Jio) -- has entered into 5 year partnership with India's leading broadcaster, Star India to unleash a new era in sports entertainment. Jio......

Sun Pharma receives Australian TGA approval for ILUMYA

Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe......